ADDING MULTIMEDIA Pall to Expand Life Sciences Manufacturing in Puerto Rico.EAST HILLS, N.Y. -- Pall Corporation Pall Corporation NYSE: PLL, formerly Micro Metallic Company, is an East Hills, New York based global business in the diverse field of filtration, separations and purification. Total revenues for fiscal 2006 were $2 billion, with over 11,000 employees and $56. (NYSE NYSE See: New York Stock Exchange : PLL PLL - phase-locked loop ), the global leader in filtration, separations and purification, announces plans to expand its Life Sciences manufacturing operations Manufacturing operations concern the operation of a facility, as opposed to maintenance, supply and distribution, health, and safety, emergency response, human resources, security, information technology and other infrastructural support organizations. in Fajardo, Puerto Rico Fajardo (fah-HAHR-do) is a small but popular city in Puerto Rico located in the east region of the island, bordering the Atlantic Ocean, north of Ceiba and east of Luquillo. . The planned establishment of a Life Sciences Center of Excellence will significantly expand Pall's capacity on the island enhancing its ability to meet the increasing demand for its high quality technologies by the world's leading pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , blood centers and hospitals. Pall expects to invest around $50 million in facilities, machinery and equipment and add more than 250 full-time jobs in Puerto Rico Puerto Rico (pwār`tō rē`kō), island (2005 est. pop. 3,917,000), 3,508 sq mi (9,086 sq km), West Indies, c.1,000 mi (1,610 km) SE of Miami, Fla. by the year 2010. The Hon. AnE bal Acevedo-VilEi, Governor of the Commonwealth of Puerto Rico and Eric Krasnoff, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Pall made the announcement today at the Pall Fajardo plant. The expansion in Puerto Rico is another step in Pall's standardization and consolidation of its global manufacturing footprint. The Company anticipates that Puerto Rico's competitive tax rate combined with its facilities optimization program will result in an incremental after tax benefit of more than $10 million annually in three years. "Puerto Rico's attractive business climate and strong commitment to developing biopharmaceutical manufacturing capability are key factors in bringing numerous drug and biotechnology companies to the island. Expanding our operations in Puerto Rico is an important part of our strategic approach of aligning with customers worldwide and increasing production in lower tax rate jurisdictions," says Mr. Krasnoff. Pall's BioPharmaceuticals business, which represents 15% of total sales, has been growing by double-digits as an increasing number of drugs go into production and the Company's market share grows. "We are extremely pleased by Pall's decision to expand in Puerto Rico as it enables us to retain a preeminent supplier to the global biopharmaceutical manufacturing industry. We will continue to work together to assure Pall's welcome here as its presence is a critical component in helping us meet our roadmap goal of extending Puerto Rico capabilities across the entire life sciences value chain," says Boris Jaskille, Executive Director of the Puerto Rico Industrial Development Company The Puerto Rico Industrial Development Company (PRIDCO), along with the Puerto Rico Government Development Bank (GDB), was created by the government of Puerto Rico in 1942, during the administration of Governor Rexford G. (PRIDCO PRIDCO Puerto Rico Industrial Development Corporation (Puerto Rican government agency) ). About Pall Corporation Pall Corporation is the global leader in the rapidly growing field of filtration, separation and purification. Pall is organized into two businesses: Life Sciences and Industrial. These businesses provide leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceutical, transfusion medicine transfusion medicine Blood banking A subspecialty of clinical pathology or internal medicine which is involved in Pt management through administration of blood cells and blood products including fresh-frozen plasma and cryoprecipitate; TM specialists are versant in , energy, electronics, municipal and industrial water purification About PRIDCO The Puerto Rico Industrial Development Company (PRIDCO) is a government-owned corporation A government corporation, government-owned corporation or government business enterprise is a legal entity created by a government to exercise some of the powers of the government. dedicated to promoting Puerto Rico as an investment destination for companies and industries worldwide. Since its establishment in the 1950, PRIDCO has been responsible for attracting over 6,000 manufacturing plants and creating more than 556,000 jobs throughout the island. PRIDCO continues to be a catalyst for Puerto Rico's economic development, leading the transformation from a traditional industrial economy to an economy based on knowledge. PRIDCO emphasizes on promoting industries with high intellectual content such as the life sciences, technology, computing and services that leverage on our people's extraordinary talent, experience and capacity for innovation. Forward-Looking Statements: Forward-looking statements contained in this and other written and oral reports are based on current Company expectations and are subject to risks and uncertainties, which could cause actual results to differ materially. All statements regarding future performance, earnings projections, earnings guidance, events or developments are forward-looking statements. Such risks and uncertainties include, but are not limited to: changes in product mix and product pricing particularly as we expand our systems business in which we experience significantly longer sales cycles and less predictable revenue with no certainty of future revenue streams from related consumable product offerings and services; increases in costs of manufacturing and operating costs including energy and raw materials; the Company's ability to achieve the savings anticipated from cost reduction and margin improvement initiatives including the timing of completion of the facilities rationalization initiative; fluctuations in foreign currency exchange rates and interest rates; regulatory approval and market acceptance of new technologies; changes in business relationships with key customers and suppliers including delays or cancellations in shipments; success in enforcing patents and protecting proprietary products and manufacturing techniques; successful completion or integration of acquisitions; domestic and international competition in the Company's global markets; and global and regional economic conditions and legislative, regulatory and political developments. The Company makes these statements as of the date of this disclosure and undertakes no obligation to update them. Management uses certain non-GAAP measurements to assess Pall's current and future financial performance. The non-GAAP measurements do not replace the presentation of Pall's GAAP GAAP See: Generally Accepted Accounting Principles GAAP See generally accepted accounting principles (GAAP). financial results. These measurements provide supplemental information to assist management in analyzing Pall's financial position and results of operations. Pall has chosen to provide this information to facilitate meaningful comparisons of past, present and future operating results and as a means to emphasize the results of ongoing operations. Editor's Note: High resolution photos of the Governor of the Commonwealth of Puerto Rico with Pall Corporation Executives and the PRIDCO press release can be found at http://www.pall.com/fajardo |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion